World’s first lung cancer vaccine given to patient in UK as human trials begin
HQ team August 23, 2024: .An mRNA-based lung cancer vaccine is being tested for the first time on patients in the UK. Known
HQ team August 23, 2024: .An mRNA-based lung cancer vaccine is being tested for the first time on patients in the UK. Known
HQ Team August 22, 2024: Even a mild concussion could lead to long-term changes in the brain, according to a new study conducted
HQ Team August 22, 2024: Smart devices such as watches and fitness trackers have surged in popularity, becoming essential tools for health and
HQ Team August 22, 2024: A new study based on data from the World Health Organization’s records on adverse drug reactions found that
The International Organization for Migration has appealed for $18.5 million in global aid to provide healthcare services to migrants, internally displaced persons, and
Molecules and microorganisms in the human body dramatically rise or fall at an average age of 44 and 60 affecting both the heart
The US regulatory body has rejected Regeneron Pharmaceuticals, Inc.,’s blood cancer drug as it did not meet the pre-approval standards of the agency.
Switzerland’s Basilea Pharmaceutica Ltd. will receive $1.25 million from its partner Pfizer Inc. after the latter exceeded the sales target for a licensed
Johnson & Johnson plans to acquire Israel’s privately-held V-Wave Ltd., for an upfront payment of $600 million, according to a statement from the
Walgreens Boots Alliance Inc., the second-largest pharmacy store chain in the US has bagged a $100 million government funding to expand its clinical